Nektar Therapeutics
NASDAQ:NKTR
Income Statement
Earnings Waterfall
Nektar Therapeutics
Revenue
|
93.1m
USD
|
Cost of Revenue
|
-30m
USD
|
Gross Profit
|
63.1m
USD
|
Operating Expenses
|
-199m
USD
|
Operating Income
|
-135.9m
USD
|
Other Expenses
|
-32.4m
USD
|
Net Income
|
-168.3m
USD
|
Income Statement
Nektar Therapeutics
Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
212
N/A
|
201
-5%
|
290
+44%
|
284
-2%
|
211
-26%
|
231
+9%
|
181
-22%
|
191
+6%
|
167
-12%
|
165
-1%
|
131
-21%
|
133
+1%
|
250
+88%
|
308
+23%
|
321
+4%
|
1 374
+328%
|
1 249
-9%
|
1 193
-4%
|
1 184
-1%
|
119
-90%
|
121
+1%
|
115
-5%
|
137
+20%
|
163
+19%
|
163
+0%
|
153
-6%
|
126
-18%
|
105
-16%
|
100
-5%
|
102
+2%
|
103
+1%
|
96
-7%
|
95
-1%
|
92
-3%
|
89
-4%
|
88
-1%
|
88
+1%
|
90
+2%
|
90
+0%
|
93
+3%
|
93
+0%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(31)
|
(29)
|
(29)
|
(34)
|
(32)
|
(34)
|
(35)
|
(32)
|
(32)
|
(30)
|
(27)
|
(29)
|
(27)
|
(31)
|
(31)
|
(28)
|
(27)
|
(24)
|
(23)
|
(23)
|
(23)
|
(21)
|
(20)
|
(21)
|
(21)
|
(20)
|
(22)
|
(23)
|
(23)
|
(25)
|
(25)
|
(22)
|
(22)
|
(22)
|
(23)
|
(25)
|
(33)
|
(34)
|
(35)
|
(38)
|
(30)
|
|
Gross Profit |
181
N/A
|
172
-5%
|
261
+51%
|
250
-4%
|
179
-28%
|
197
+10%
|
146
-26%
|
159
+9%
|
135
-15%
|
135
0%
|
104
-23%
|
104
+0%
|
222
+113%
|
277
+25%
|
290
+5%
|
1 347
+364%
|
1 222
-9%
|
1 169
-4%
|
1 160
-1%
|
97
-92%
|
98
+1%
|
93
-5%
|
117
+26%
|
142
+21%
|
142
+0%
|
133
-6%
|
105
-22%
|
82
-21%
|
77
-6%
|
77
0%
|
79
+2%
|
74
-5%
|
74
-1%
|
70
-4%
|
66
-7%
|
63
-5%
|
56
-11%
|
56
+2%
|
55
-3%
|
55
+0%
|
63
+14%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(196)
|
(189)
|
(198)
|
(207)
|
(216)
|
(226)
|
(242)
|
(250)
|
(260)
|
(248)
|
(262)
|
(275)
|
(290)
|
(321)
|
(382)
|
(414)
|
(458)
|
(481)
|
(506)
|
(527)
|
(529)
|
(533)
|
(525)
|
(517)
|
(521)
|
(513)
|
(505)
|
(515)
|
(521)
|
(523)
|
(530)
|
(463)
|
(386)
|
(311)
|
(228)
|
(212)
|
(201)
|
(192)
|
(188)
|
(190)
|
(199)
|
|
Selling, General & Administrative |
(38)
|
(41)
|
(41)
|
(42)
|
(42)
|
(43)
|
(43)
|
(44)
|
(45)
|
(44)
|
(46)
|
(51)
|
(53)
|
(52)
|
(59)
|
(63)
|
(70)
|
(81)
|
(88)
|
(90)
|
(95)
|
(99)
|
(100)
|
(102)
|
(105)
|
(105)
|
(110)
|
(115)
|
(118)
|
(123)
|
(119)
|
(109)
|
(102)
|
(92)
|
(86)
|
(83)
|
(82)
|
(77)
|
(76)
|
(79)
|
(77)
|
|
Research & Development |
(157)
|
(148)
|
(156)
|
(165)
|
(174)
|
(183)
|
(185)
|
(192)
|
(201)
|
(204)
|
(216)
|
(224)
|
(237)
|
(269)
|
(307)
|
(335)
|
(372)
|
(400)
|
(419)
|
(437)
|
(433)
|
(435)
|
(425)
|
(415)
|
(416)
|
(409)
|
(395)
|
(400)
|
(403)
|
(400)
|
(412)
|
(353)
|
(283)
|
(218)
|
(142)
|
(129)
|
(119)
|
(114)
|
(111)
|
(111)
|
(122)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
(14)
|
(14)
|
(14)
|
0
|
0
|
0
|
0
|
0
|
(16)
|
(16)
|
(16)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(15)
N/A
|
(17)
-11%
|
63
N/A
|
42
-33%
|
(38)
N/A
|
(29)
+22%
|
(96)
-227%
|
(91)
+5%
|
(124)
-37%
|
(113)
+9%
|
(158)
-40%
|
(170)
-8%
|
(68)
+60%
|
(44)
+36%
|
(92)
-111%
|
932
N/A
|
764
-18%
|
688
-10%
|
654
-5%
|
(431)
N/A
|
(431)
0%
|
(440)
-2%
|
(408)
+7%
|
(374)
+8%
|
(379)
-1%
|
(380)
0%
|
(401)
-6%
|
(433)
-8%
|
(444)
-2%
|
(446)
0%
|
(452)
-1%
|
(388)
+14%
|
(312)
+20%
|
(240)
+23%
|
(162)
+33%
|
(149)
+8%
|
(145)
+3%
|
(135)
+7%
|
(133)
+2%
|
(135)
-2%
|
(136)
-1%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(39)
|
(38)
|
(37)
|
(37)
|
(36)
|
(37)
|
(38)
|
(39)
|
(41)
|
(40)
|
(39)
|
(38)
|
(36)
|
(36)
|
(36)
|
(25)
|
(15)
|
(5)
|
5
|
4
|
3
|
0
|
(6)
|
(9)
|
(15)
|
(19)
|
(28)
|
(40)
|
(51)
|
(53)
|
(13)
|
(4)
|
7
|
11
|
(18)
|
(12)
|
(8)
|
(6)
|
(5)
|
(7)
|
(9)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
(14)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(16)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(45)
|
(45)
|
(45)
|
(45)
|
0
|
0
|
0
|
0
|
(2)
|
(108)
|
(124)
|
(136)
|
(232)
|
(143)
|
(137)
|
(128)
|
(32)
|
(29)
|
(17)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(24)
|
(24)
|
(25)
|
(25)
|
0
|
0
|
0
|
0
|
(6)
|
(6)
|
(6)
|
(7)
|
|
Pre-Tax Income |
(54)
N/A
|
(54)
-2%
|
26
N/A
|
6
-78%
|
(73)
N/A
|
(81)
-10%
|
(134)
-66%
|
(130)
+3%
|
(165)
-27%
|
(153)
+8%
|
(197)
-29%
|
(208)
-6%
|
(104)
+50%
|
(96)
+8%
|
(128)
-33%
|
907
N/A
|
749
-17%
|
683
-9%
|
659
-4%
|
(427)
N/A
|
(428)
0%
|
(440)
-3%
|
(459)
-4%
|
(429)
+7%
|
(439)
-2%
|
(444)
-1%
|
(429)
+3%
|
(474)
-11%
|
(495)
-4%
|
(523)
-6%
|
(491)
+6%
|
(525)
-7%
|
(454)
+13%
|
(365)
+20%
|
(412)
-13%
|
(304)
+26%
|
(291)
+4%
|
(276)
+5%
|
(176)
+36%
|
(177)
-1%
|
(168)
+5%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(2)
|
1
|
1
|
1
|
1
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
248
|
247
|
244
|
245
|
(1)
|
(0)
|
3
|
2
|
(1)
|
(3)
|
(2)
|
(2)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
(3)
|
(3)
|
(3)
|
(3)
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(56)
|
(54)
|
26
|
6
|
(73)
|
(81)
|
(135)
|
(130)
|
(165)
|
(154)
|
(198)
|
(209)
|
(105)
|
152
|
120
|
1 151
|
994
|
681
|
659
|
(424)
|
(427)
|
(441)
|
(462)
|
(431)
|
(441)
|
(444)
|
(429)
|
(474)
|
(495)
|
(524)
|
(491)
|
(525)
|
(454)
|
(368)
|
(415)
|
(307)
|
(294)
|
(276)
|
(176)
|
(177)
|
(168)
|
|
Net Income (Common) |
(56)
N/A
|
(54)
+4%
|
26
N/A
|
6
-77%
|
(73)
N/A
|
(81)
-12%
|
(135)
-66%
|
(130)
+3%
|
(165)
-27%
|
(154)
+7%
|
(198)
-29%
|
(209)
-6%
|
(105)
+50%
|
(97)
+8%
|
(129)
-33%
|
903
N/A
|
746
-17%
|
681
-9%
|
659
-3%
|
(424)
N/A
|
(427)
-1%
|
(441)
-3%
|
(462)
-5%
|
(431)
+7%
|
(441)
-2%
|
(444)
-1%
|
(429)
+4%
|
(474)
-11%
|
(495)
-4%
|
(524)
-6%
|
(491)
+6%
|
(525)
-7%
|
(454)
+13%
|
(368)
+19%
|
(415)
-13%
|
(307)
+26%
|
(294)
+4%
|
(276)
+6%
|
(176)
+36%
|
(177)
-1%
|
(168)
+5%
|
|
EPS (Diluted) |
-0.42
N/A
|
-0.42
N/A
|
0.19
N/A
|
0.03
-84%
|
-0.56
N/A
|
-0.61
-9%
|
-1
-64%
|
-0.96
+4%
|
-1.22
-27%
|
-1.1
+10%
|
-1.28
-16%
|
-1.34
-5%
|
-0.64
+52%
|
-0.61
+5%
|
-0.79
-30%
|
4.95
N/A
|
4.31
-13%
|
3.78
-12%
|
3.78
N/A
|
-2.38
N/A
|
-2.44
-3%
|
-2.52
-3%
|
-2.61
-4%
|
-2.43
+7%
|
-2.48
-2%
|
-2.49
0%
|
-2.36
+5%
|
-2.59
-10%
|
-2.69
-4%
|
-2.86
-6%
|
-2.64
+8%
|
-2.8
-6%
|
-2.44
+13%
|
-1.97
+19%
|
-2.21
-12%
|
-1.63
+26%
|
-1.56
+4%
|
-1.45
+7%
|
-0.92
+37%
|
-0.84
+9%
|
-0.8
+5%
|